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ABSTRACT 
YUJING ZHANG: Intravenous Solution Wastage in Hospital Pharmacy at Baptist 
Memorial Hospital-North Mississippi (Oxford) 
(Under the direction of Erin Holmes) 
 
 
Introduction: IV solution wastage refers to IV medications made for a patient that 
remain unused by that patient for a variety of reasons, and have subsequently expired, 
or for other reasons cannot be used for another patient (recycled), and therefore must 
be disposed of. This problem is widespread across hospital pharmacies in the U.S. 
and the world. BMH-NM (Oxford) pharmacy utilizes many waste reduction strategies 
but has never monitored its IV solution wastage. Therefore, the objective of this study 
was to identify the number of IV solutions wasted in a month and the subsequent 
financial loss in terms of drug cost, and categorize the wastage by drug name and 
drug class. Methods: This study was conducted using a cross-sectional, observational, 
prospective study design to quantify the amount of IV solution wastage that occurred 
at BMH-NM (Oxford). For 30 days in March, 2017, the researcher collected data 
from wasted IV solutions set aside by pharmacy technicians and calculated the drug 
cost. For each wastage indicator (number of bags and drug cost), the top 10 drugs and 
drug classes were ranked, and descriptive statistics were conducted to further 
visualize the impact. Results: From March 1, 2017, to March 30, 2017, the BMH-
NM (Oxford) pharmacy wasted 285 bags of IV solution, resulting in a financial loss 
of $4025.66 in drug cost. There were 46 different types of drugs from 28 different 
drug classes. Conclusion: The financial loss from a single month of IV solution 
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wastage was significant for a 217-bed rural hospital. A variety of drugs and drug 
classes were identified as targets for waste reduction. Potential causes for wastage 
were drug-specific, and both volume and cost of waste need to be considered for 
reducing overall IV solution wastage.  
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BACKGROUND 
Description of the Problem 
 In hospital pharmacies across the country, and even the world, pharmacists and 
technicians experience the frustration of intravenous (IV) solution wastage. This wastage 
refers to IV medications made for a patient that remain unused by that patient for a 
variety of reasons, and have subsequently expired, or for other reasons cannot be used for 
another patient (recycled), and therefore must be disposed of.  
There can be several negative consequences that result from wasted IV solutions. 
On the anecdotal side, IV solution wastage could lead to reduced work satisfaction and 
reduced productivity in the pharmacy. It takes time and resources for technicians and 
pharmacists to verify the order, prepare the solution, double-check the bag, and send it to 
the appropriate location. Seeing IV bags go to waste and realizing that all the work was 
done in vain can sometimes be frustrating and discouraging to the pharmacy staff. In 
addition, they could have used that time verifying other orders or preparing other 
medication, resulting in opportunity costs for labor.  
On the quantitative side, the financial cost of IV solution wastage can be a 
significant burden on a hospital pharmacy’s budget. Uchida et al. (1994) conducted a 
year-long study at the 493-bed University of California, Irvine Medical Center in 1991 
and found 14,035 wasted IV solutions totaling an estimated $86,000 in drug costs, or 2.5% 
of the total IV drug cost, in a 12-month period. Accounting for inflation, the loss equates 
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to about $150,000 in today's value. Of course, other factors over the past 25 years, such 
as healthcare reform and rising drug costs, may realistically result in a much higher 
wastage cost. 
 
Literature Evaluation of IV Solution Wastage 
 Because IV solution wastage is a serious and widespread problem in hospital 
pharmacies, many researchers around the world have looked into the magnitude of waste 
in their local hospitals. In an 800-bed teaching hospital in Saudi Arabia, for example, Al-
Dhawailie (2011) collected 265 unused intravenous medication in a single month in 2009. 
A year earlier at a large teaching hospital in Cincinnati, OH, Chiu (2009) found that an 
average of 2,173 IV bags was wasted per month during a 3-month study period, costing 
the pharmacy on average $47,977 each month and an estimated $575,000 per year. A 
dated, but more comprehensive study, conducted by Birdwell et al. (1993) showed that 
among 237 surveyed U.S. hospitals, the mean IV solution wastage rate was 2.83%—
meaning for every 100 bags made, 3 were wasted. Most alarming is that despite hospital 
pharmacies being aware of the issue of IV solution wastage, only a minority of those 
pharmacies regularly monitor for IV wastage. In the same survey by Birdwell, only 35.9% 
of the respondents indicated that waste is monitored and recorded on a daily basis. Over 
40% said that they either only monitored waste occasionally or never monitor it at all.
 
 
Causes of IV Solution Wastage 
 Quantifying IV wastage is important, but it is also important to understand the 
causes of wasted IV solutions. Just like everything else in health care, the reasons are 
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complicated. Most often, IV bags are wasted because they have short expiration dates, 
and by the time technicians bring them back to the pharmacy, they can no longer be 
recycled. There are several reasons why IV bags are returned to the pharmacy. Usually it 
is because the doctor discontinued or changed the order, and the solution has already 
been mixed and sent up to the floor. Other times nurses do not transfer the medication 
with the patient to a different unit, causing the bag to expire in a medication bin on the 
patient’s old floor. Lastly, if a patient passed away before the medication was due, but 
after it was made, the nurse has no choice but to return the bag to pharmacy. Uchida 
(1994) observed in her article, "most of these problems can be attributed to poor 
communication between physicians, nurses, and pharmacists."  
 
Methods to Reduce IV Solution Wastage 
 From my personal experience working for three years as a hospital pharmacy 
technician, potential IV solution wastage is inevitable, but many times it is avoidable. 
There are many measures to reduce waste. Birdwell et al. (1993) focused on four areas. 
First, he found that the lowest wastage rate occurred when there is computerized 
notification (versus written or verbal notification) to discontinue IV administration. 
Specifically, "as the elapsed time from the discontinuation of an IV drug or solution to 
notification in the pharmacy increased from <1 hour to >4 hours, the actual and perceived 
mean wastage rates also increased." Second, he found that the active retrieval of IV 
solution from wards or from designated location reduced wastage rate. Third, 85.9% of 
the surveyed hospitals recycled IV bags until their expiration date, and compared to more 
conservative recycling policies, this policy had the lowest wastage rates.  Lastly, the 
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highest wastage rates came from hospitals that used manufacturer stability data in 
determining the expiration dating policy, while the lowest rates came from the handful of 
hospitals who used sterility instead of stability data. Again, Birdwell's survey was 
conducted in 1990 when computerized physician order entry (CPOE) system was not yet 
widespread, so today there are many other methods, such as barcode scanning technology, 
that could be used to reduce intravenous solution wastage. 
 
Baptist Memorial Hospital-North Mississippi (Oxford) Pharmacy Efforts to Reduce 
Wastage 
 The pharmacy at Baptist Memorial Hospital-North Mississippi (BMH-NM) in 
Oxford, a 217-bed large rural hospital, already incorporates many of these best practices 
to reduce waste. When physicians order certain IV solutions (e.g., those with short 
stability periods or those that are made with expensive drugs) using a CPOE system, 
pharmacists process the order as usual. However, technicians pin the label on a board 
outside the IV room rather than immediately making the IV after the order is placed. An 
hour before the medication is due, the technician checks to see if the order has been 
discontinued or if the patient has been transferred. If the order is still active, and the 
patient location is updated, then the technician will make the bag, and the medication will 
be either sent by pneumatic tube or hand-delivered to the nursing unit.  
There are several other mechanisms that the pharmacy at BMH-NM (Oxford) has 
in place to minimize IV wastage. When technicians are on nursing floors on routine 
medication deliveries, they will actively retrieve unused IV bags that were due at least 6 
hours ago, and once the technician gets back to the pharmacy, they will credit the bags 
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back to the patients (meaning, to ultimately remove this IV from the patient’s hospital 
bill). If not expired, these IVs will be stored for the purpose of reuse for other patients as 
appropriate (see batch fill process section, below). 
In other instances, when the IV technician makes extra bags for frequently used 
solutions, he or she will put the new bags behind the old ones in the overstock bin so the 
ones expiring first will get used first. Also, to avoid IV bags from going missing on 
nursing units, the technicians try to hand deliver as many IV bags as possible to the 
medication room on the nursing unit instead of sending them by pneumatic tube to the 
nursing unit. If a nurse calls the pharmacy for replacements of missing IV bags because a 
patient has recently transferred from a different floor, the tech will call the nurse from the 
patient's previous floor to try to find the bag before making a new one. Finally, for IV 
bags with short stability, the hospital pharmacy purchases premixed bag with longer 
expiration dates. 
 
Batch Fill Process of IV Solutions at BMH-NM (Oxford) 
 To fully understand how IV wastage is managed at BMH-NM (Oxford), it is 
important to understand the daily process of filling IV orders for patients. Every morning 
at 7:00 am, labels are printed for IVs due between noon and 6:00 pm that day. The IVs 
are made and delivered at 9:30 am. The timeline for the second, third, and fourth batches 
of IVs for the day are outlined in Table 1 below.  
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Table 1. IV Batch Fill Process at BMH-NM Pharmacy. 
7:00 AM First batch prints for IVs due noon to 6 PM today 
9:30 AM Rounder delivers first batch 
11:00 AM Second batch prints for IVs due 6 PM to midnight today 
2:00 PM Rounder delivers second batch 
3:00 PM Third batch prints for IVs due midnight to 6 AM tomorrow 
4:00 PM Rounder delivers third batch 
6:00 PM Fourth batch prints for IVs due 6 AM to noon tomorrow 
7:30 PM Rounder delivers fourth batch 
 
 In addition to the scheduled IV batches illustrated above, labels for new orders, 
STAT doses (immediate does for patients), and PRN (as needed) doses print out 
sporadically throughout the day. The IV technician usually makes these bags as soon as 
the labels print out, and the mixed solutions are tubed to the floor, unless it contains drugs 
that cannot be shaken or are narcotics, in which case the bags will be hand-delivered to 
the nurse.  
 
Recycling and Wasting Policy at BMH-NM (Oxford) 
 BMH-NM (Oxford) has established a process for collecting discontinued IV bags. 
Every time an IV order gets discontinued, a D/C (shorthand for “Discontinue”) label 
prints out. If the label prints out before the rounding technician delivers, then a technician 
would first try to find the original label and credit it before a bag is even made, or if the 
bag is already made, find the bag, credit it, and save it for use for another patients 
(recycling). If the D/C label prints out after the rounder has left the pharmacy for delivery, 
then the next rounding technician will bring the discontinued bag back and credit it. The 
IV bag will be stored for use for another patient if appropriate. If the solution has already 
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expired and cannot be recycled for another use, then the bag will be cut up in the sink as a 
means of destruction.  
 In addition to making IV solutions for specific patients, the pharmacy also 
prepares commonly used IV bags in bulk to be stored in the pharmacy and in different 
hospital units, which can be another source of IV solution wastage. As mentioned in the 
previous section, technicians often make extra IV bags for frequently used drugs, and 
occasionally the extra bags expire before they can be used. In nursing units, BMH-NM 
(Oxford) installed Omnicell Automated Dispensing Cabinets in 2015 to store unit-dose 
medication, premixed fluids, and frequently prescribed IV solutions with a 15-day or 30-
day stability period at room temperature. These medication cabinets allow nurses to 
retrieve medication for their patients instantly instead of waiting on pharmacy technicians 
to deliver or tube the medication. Every day, an item expiration tracking report prints out, 
detailing every item in every Omnicell cabinet that will expire in the next 30 days. In this 
way, technicians keep track of which IV solutions are expiring in which Omnicell cabinet, 
and every weekend the rounding technicians bring back bags that expire in the following 
week to be cut up in the sink. 
 
Study Significance 
 Conducting a study to monitoring IV solution wastage at BMH-NM (Oxford) is 
important for several reasons. First, there has been little recent research on IV solution 
wastage in the United States, especially in rural hospitals. It will be interesting to see how 
findings at BMH-NM (Oxford) compare with numbers from previous studies and at large 
teaching hospitals. Second, this hospital pharmacy has never monitored its drug wastage, 
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even though inefficiencies arising from IV wastage have been noted. Lastly, this research 
can have important financial and policy implications for the pharmacy. Anecdotally, 
BMH-NM (Oxford) has often been referred to as the "cash cow" for the Baptist 
healthcare corporation. Quantifying IV solution waste and subsequent financial costs has 
the potential to create real policy changes within the pharmacy and the hospital at large. 
 
Study Objectives 
 The overall purpose of this study is to monitor and quantify IV solution wastage 
at the pharmacy at BMH-NM (Oxford). The specific objectives of this study are: 
1. To identify the number of IV solutions wasted at BMH-NM (Oxford) in a month 
and to categorize the solutions by drug name and drug class. 
2. To quantify the financial loss in terms of drug cost to BMH-NM (Oxford) as a 
result of wasted IVs at BMH-NM (Oxford) pharmacy and categorize the loss by 
drug name and drug class. 
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METHODS 
Study Design 
 This study was conducted using a cross-sectional, observational, prospective 
study design to quantify the amount of IV solution wastage that occurred at BMH-NM 
(Oxford). The study was approved by the Baptist Memorial Healthcare Corporation IRB 
as well as the University of Mississippi IRB. 
 
Data Collection  
 In February 2017, the researcher prepared the pharmacy staff at BMH-NM 
(Oxford) for the data collection by holding a staff meeting with the pharmacy technicians 
and sending an email to technicians and pharmacists about the study. Technicians were 
given detailed instructions pertaining to the collection process in the meeting as well as in 
the email, and pharmacists were given a broad overview of the study purpose and method 
in the email so that they were aware of the ongoing data collection. The data collection 
process was piloted prior to the start of the study to assure adherence to, and 
understanding of, procedures. 
 There are three general sources of wasted IV solutions: unused bags from nursing 
units, expired pre-made bags in Omnicell machines, and expired bags in refrigerator 
overstock bins in the pharmacy. Technicians were given separate instructions for each 
source.  
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 For bags returned from daily rounding and retrieved from nursing units 
(see Figure 1), technicians were told to sort out the wasted IV solutions, 
leave the medication labels intact, and place the wasted IV bags in one of 
the designated collection bins in the pharmacy. They were instructed not 
to credit the bags back to the patients to avoid the reflex of tearing off the 
label immediately after crediting. To assure them that the bags would still 
be credited, they were told that the researcher would credit the bags once 
she finishes data collection for the day.  
 For expired pre-made bags returned from Omnicell machines, technicians 
were instructed to simply place them in the collection bins. These bags 
would be identified as Omnicell expires because they lack medication 
labels.  
 For bags that expired in the pharmacy refrigerator, technicians were 
similarly instructed to place them in the collection bins instead of cutting 
them up in the sink. These bags would be identified as overstock expires 
because they would have incomplete medication labels that lack the 
section with patient-identifying information.  
 If technicians accidentally tore off medication labels or cut up the bags in the sink, 
they were told to put the unlabeled or empty bags in the collection bins regardless so that 
the researcher can get an accurate count of the number of IV bags wasted. 
 The physical preparation for data collection included hanging up signs in 
conspicuous areas of the pharmacy to remind technicians on the data collection process 
and setting up two collection bins in the pharmacy. Three signs were hung: one above the 
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computer at the technician island, one below the monitor of the computer used for 
crediting medications, and one above the sink in the IV room. These locations were 
chosen because they are visible to technicians and are key sites where wasted IV bags are 
normally processed. Two labeled collection bins were set up: one next to the crediting 
computer, and one near the sink in the clean room.  
 Data collection began on March 1st, 2017, and ended on March 30, 2017. Each 
day at 8 pm, the researcher went to the pharmacy to check the collection bins, enter data 
onto an encrypted data collection Excel spreadsheet, credit appropriate bags back to the 
patients, and properly dispose of the wasted IV solutions by tearing off and shredding the 
medication labels and cutting the bags up in the sink. 
 The encrypted data collection Excel spreadsheet, henceforth referred to as the 
daily log, is a table with descriptions of each wasted bag in rows (see Table 2 below). 
The descriptors included bag number, hospital unit, drug name, dose strength, and order 
type. Each bag was coded using a 6-digit code: the first three numbers indicated the date 
of collection, and the last three numbers differentiated bags wasted on the same day. The 
hospital unit was the unit on the medication label, not necessarily where the technician 
retrieved the bag. For example, bags expired in the fridge might be a recycled bag 
returned from a nursing unit, but because the patient-identifying section of the medication 
label, which contains the unit number, has been removed, the bag is only identifiable as 
fridge overstock. The drug name and dose strength were either identified from the 
medication label or, in the case of the pre-made bags expired in Omnicell machines, from 
the attached vials. The order type indicated whether the bag was made as a first dose 
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(FD), a PRN (as needed) dose, a scheduled dose that was printed in the IV batch (CF), or 
a redispensed dose to replace a missing dose.  
Table 2. Sample Daily Log 
Date: 
3/1/2017 
Bag # Unit Drug Dose Order 
Type 
 301001 2nd Potassium 
Chloride 
40mEq/20ml CF 
 301002 SD Ibuprofen 400mg CF 
 301003 ER Thiamine 100mg FD 
 301004 Omnicell meropenem 500mg restock 
 
 At the end of the 30-day collection period, the researcher provided the pharmacy 
buyer with a list of drug products with specific brand/drug name, concentration, and vial 
sizes used to make each of the wasted IV solutions from the daily log. The specific 
products were determined based on the standardized process of sterile compounding at 
the BMH-NM (Oxford) pharmacy, which is knowledge that I acquired from working as a 
technician at this pharmacy for three years. For example, three different types of 
vancomycin vials are used to prepare three different dosage strengths: a 750mg Add-
Vantage vial for the 750mg dose, a 1g Add-Vantage vial for the 1g dose, and a 5g bulk 
vial for any doses above 1g. The buyer then provided the cost of each item in unit price 
($/vial) format in a report generated from the wholesaler website. 
 
Data Analysis 
 A list of all of the drugs wasted was compiled by alphabetizing the "Drug" 
column in the daily log. Then the number of bags wasted was summed for each dosage 
strength of each drug.  
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 Next, the drug cost of each bag was calculated by determining the unit dose 
multiplier (i.e. the number of vials used) for each bag. Using the standardized process for 
sterile compounding as a guide, the researcher normalized the different dose strengths of 
each drug to a unit price multiplier (see Figure 1). By multiplying the unit price multiplier 
with the unit price of each product, the drug cost of each wasted IV solution was 
calculated. 
 Next, the total number of bags for each drug was calculated by summing the 
number of bags for each dosage strength. Similarly, the total drug cost was calculated for 
each drug.  
 To calculate wastage by drug class, the pharmacological class of each drug was 
determined using Lexi-Comp. Then the drugs were grouped into various classes. Within 
each class, each drug's wastage was summed to calculate wastage by number of bags and 
by drug cost per drug class.  
 For each of the four wastage indicators (number of bags wasted by drug, number 
of bags wasted by drug class, drug cost by drug, and drug cost by drug class), the 
numerical value was sorted from highest to lowest to reflect the impact on IV wastage by 
each drug or drug class. Descriptive statistics was conducted to further visualize the 
impacts. 
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Figure 1. Unit Price Multiplier Calculation 
 
 
 
 
 
Does this 
drug come 
in single 
dose or 
multidose 
vials? 
Single Dose 
If the dose strength is the same as the total amount in the 
vial (i.e. the entire content of the vial was used to make the 
bag), the unit price multiplier is 1 
If the dose strength is more than the total amount in one vial 
(e.g. 10 ml of drug is in the bag and the vial size is 5 ml), divide 
the dose strength by the amount in one vial and round the 
number up to the nearest whole number 
If the dose strength is exactly half of the total amount in one 
vial (e.g. 4 ml of drug is in the bag and the vial holds 8 ml), 
sum the total number of bags with this dose strength and 
divide by 2, round up to the nearest whole number 
Any other dose strength less than the total 
amount in one vial has a unit price multiplier 
of 1 
Multidose 
sum all dose strength in terms of volume (ml) 
and divide by the volume in one vial, rounding 
up to the nearest whole number 
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RESULTS 
 From March 1, 2017, to March 30, 2017, the BMH-NM (Oxford) pharmacy 
wasted 285 bags of IV solution, resulting in a financial loss of $4025.66 in drug cost. 
There were 46 different types of drugs from 28 different drug classes. Table 3 gives a 
summary of the total IV solution wastage for each drug as well as an index for the drug 
class that each drug is in.  
 The top ten drugs wasted by number of bags included potassium chloride, 
meropenem, penicillin G potassium, cefazolin, ibuprofen, thiamine, vancomycin, folic 
acid, phenylephrine, and multivitamin infuvite (Table 4). These drugs represented 68% of 
the total waste by number of bags (Figure 2).  
 The top ten drug classes wasted by number of bags included electrolytes, vitamins, 
penicillin antibiotics, carbapenem antibiotics, cephalosporin antibiotics, NSAIDs, 
glycopeptide antibiotic, alpha-adrenergic agonist, aminoglycoside antibiotics, and 
anticonvulsant (Table 5). These drug classes represented 83% of the total waste by 
number of bags (Figure 3). 
 The top ten drugs wasted by drug cost included vasopressin, daptomycin, 
ceftaroline fosamil, nitroprusside, meropenem, norepinephrine, aztreonam, anidulafungin, 
sodium bicarbonate, and phenylephrine (Table 6). These drugs represented 71% of the 
total loss in drug cost (Figure 4). 
 The top ten drug classes wasted by drug cost included hormone analog 
antidiuretic, cephalosporin antibiotics, cyclic lipopeptide antibiotic, electrolytes, 
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vasodilator antihypertensive, antifungal, carbapenem antibiotics, alpha-/beta- agonist, 
monobactam antibiotics, and vitamins (Table 7). These drug classes represented 79% of 
the total loss in drug cost (Figure 5). 
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Table 3. Total IV Solution Wastage in a 30-Day Period 
Drug Class Drug Name Total 
Waste (# of 
bags) 
Total Waste 
($) 
alpha-/beta- agonist norepinephrine 1 175.1 
alpha-adrenergic agonist phenylephrine 12 121.1 
Analgesic Acetaminophen 2 63.24 
antianginal diltiazem 2 21.24 
antibiotic, aminoglycoside gentamicin 6 50.58 
antibiotic, aminoglycoside tobramycin 2 65.55 
antibiotic, carbapenem Meropenem 31 186.25 
antibiotic, cephalosporin cefazolin 20 40.22 
antibiotic, cephalosporin cefepime 2 2.31 
antibiotic, cephalosporin ceftaroline fosamil 3 434.37 
antibiotic, cephalosporin ceftriaxone 1 6.33 
antibiotic, cyclic 
lipopeptide 
daptomycin 1 458.8 
antibiotic, glycopeptide vancomycin 14 82.58 
antibiotic, macrolide azithromycin 3 11.16 
antibiotic, miscellaneous bacitracin 5 23.4 
antibiotic, monobactam aztreonam 5 173.69 
antibiotic, penicillin Ampicillin 1 1.79 
antibiotic, penicillin ampicillin-sulbactam 8 14.76 
antibiotic, penicillin penicillin G potassium 25 76.31 
antibiotic, penicillin piperacillin-tazobactam 6 13.8 
anticonvulsant Levetiracetam 6 22.96 
anticonvulsant valproate sodium 1 2.2 
antidiarrheal octroetide 2 24.2 
antidiuretic hormone analog vasopressin 3 734.88 
antiemetic ondansetron 1 1.15 
antifungal anidulafungin 4 168.56 
antifungal fluconazole 3 25.29 
antihypertensive, diuretic bumetanide 1 1.85 
antihypertensive, diuretic chlorothiazide 1 48.84 
antihypertensive, diuretic furosemide 3 5.82 
antihypertensive, 
vasodilator 
nitroprusside 1 280.92 
Antiviral Acyclovir 1 17.6 
corticosteroid methylprednisolone 
succinate 
3 58.22 
electrolyte sodium bicarbonate 10 144.72 
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Table 3. Total IV Solution Wastage in a 30-Day Period (continued) 
Drug Class Drug Name Total 
Waste (# of 
bags) 
Total Waste 
($) 
electrolyte calcium glucanate 1 4.02 
electrolyte potassium chloride 40 96.72 
electrolyte potassium phosphate 3 38.28 
electrolyte sodium chloride 5 12.6 
electrolyte sodium phosphate 4 38.28 
insulin Humulin R 6 2.54 
iron salt sodium ferric gluconate 1 19.66 
NSAID Ibuprofen 18 79.65 
oxytocic agent oxytocin 4 11 
vitamin folic acid 13 19.6 
vitamin MVI infuvite 12 92.76 
vitamin thiamine 18 50.76 
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Table 4. Top 10 Drugs by Number of Bags Wasted 
Drug Name Total Waste (# of bags) 
Potassium Chloride 40 
Meropenem 31 
Penicillin G Potassium 25 
Cefazolin 20 
Ibuprofen 18 
Thiamine 18 
Vancomycin 14 
Folic Acid 13 
Phenylephrine 12 
MVI Infuvite 12 
 
 
 
Figure 2. Percentage of Top 10 Drugs in Total Number of Bags Wasted 
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Table 5. Top 10 Drug Classes by Number of Bags Wasted 
Drug Class Total Waste (# of bags) 
Electrolyte 63 
Vitamin 43 
Antibiotic, Penicillin 40 
Antibiotic, Carbapenem 31 
Antibiotic, Cephalosporin 26 
NSAID 18 
Antibiotic, Glycopeptide 14 
Alpha-Adrenergic Agonist 12 
Antibiotic, Aminoglycoside 8 
Anticonvulsant 7 
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Table 6. Top 10 Drugs by Drug Cost 
Drug Name Total Waste ($) 
Vasopressin 734.88 
Daptomycin 458.8 
Ceftaroline Fosamil 434.37 
Nitroprusside 280.92 
Meropenem 186.25 
Norepinephrine 175.1 
Aztreonam 173.69 
Anidulafungin 168.56 
Sodium Bicarbonate 144.72 
Phenylephrine 121.1 
 
 
 
Figure 4. Percentage of Top 10 Drugs in Total Drug Cost 
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Table 7. Top 10 Drug Classes by Drug Cost 
Drug Class Total Waste ($) 
Antidiuretic Hormone Analog 734.88 
Antibiotic, Cephalosporin 483.23 
Antibiotic, Cyclic Lipopeptide 458.8 
Electrolyte 334.62 
Antihypertensive, Vasodilator 280.92 
Antifungal 193.85 
Antibiotic, Carbapenem 186.25 
Alpha-/Beta- Agonist 175.1 
Antibiotic, Monobactam 173.69 
Vitamin 163.12 
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 There were only two drugs that were in both the top 10 drugs wasted by number 
of bags and by drug cost: meropenem and phenylephrine. Tables 8 and 9 are summaries 
of the daily log. All 31 of the meropenem bags were expired from Omnicell machines. 
All 12 of the phenylephrine infusions were expired bags retrieved from the IV room 
fridge. 
Table 8. Meropenem Daily Log Summary 
Dose Location Order Type # of Bags Drug Cost ($) 
500mg Omnicell Restock 18 76.14 
1g Omnicell Restock 13 110.11 
Total   31 186.25 
 
Table 9. Phenylephrine Daily Log Summary 
Dose Location Order Type # of Bags Drug Cost ($) 
20mg Fridge Overstock 5 40.4 
20mg Fridge PRN 3 24.24 
20mg Fridge FD 1 8.08 
40mg Fridge Overstock 2 32.32 
40mg Fridge PRN 1 16.16 
Total   12 121.2 
 
 There were 4 drug classes that were represented in the top 10 drug classes wasted 
both by number of bags and by drug cost:  
 electrolytes: sodium bicarbonate, calcium gluconate, potassium chloride, 
potassium phosphate, sodium chloride, sodium phosphate 
 vitamin: folic acid, multivitamin infuvite, thiamine 
 carbapenem antibiotics: meropenem 
 cephalosporin antibiotics: cefazolin, cefepime, ceftaroline fosamil, ceftriaxone 
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 Figure 6 shows how each drug in these 4 drug classes compare in terms of 
number of bags wasted and drug cost. The red line and the y-axis on the right represent 
the total drug cost of each drug. The cost of each drug is labeled on the graph. The blue 
bars and the y-axis on the left represent the number of bags wasted for each drug. 
 
 
Figure 6. Comparison of IV Wastage by Number of Bags Wasted and by Drug Cost 
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DISCUSSION 
Major Findings 
 In a 30-day period in March 2017, The BMH-NM (Oxford) pharmacy wasted 
over 280 IV solution bags, resulting in over $4000 of financial loss in drug cost alone. 
This wastage is significant for a rural hospital pharmacy with a limited budget. The 
following discussion will examine the meaning of the findings in relation to the two study 
objectives and why the findings are important. 
 
1. Categorizing the IV solution wastage by drug and drug class 
 The top ten drugs wasted by number of bags represent IV solutions that were 
wasted the most often. To examine the possible reasons behind their large wastage, one 
needs to understand when and where these solutions are made and stored.  
 Within these top 10 drugs, 5 drugs are kept in separate overstock bins in the IV 
fridge, meaning these bags are made in batches in anticipation of orders. These drugs 
include potassium chloride, penicillin G potassium, cefazolin, ibuprofen, and vancomycin. 
Because they are prescribed often, making them ahead of time in batches reduces the 
workload compared to making them one bag at a time as needed. The disadvantage of 
making them in bulk is that sometimes supply exceeds demand, and these bags may 
remain unused and expire in the fridge. The expiration time for these drugs vary, from 3 
days for potassium chloride to 2 weeks for vancomycin, and one can see how drugs with 
shorter expiration time can be wasted at a higher rate.  
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Another disadvantage of making these bags in advance has to do with missing medication. 
Nurses frequently contact the pharmacy about missing IV doses, and usually pharmacy 
technicians try their best to locate the missing bag before asking the IV technician to 
make a replacement bag, since it is frustrating for the IV technician to go through the 
trouble of gowning up just to make a single IV bag that he or she has already made earlier 
that day. For these "ready-to-go" IV solutions, however, technicians have less incentive 
to look for the missing dose, since replacing the missing bag is as easy as opening the 
fridge and grabbing another bag out of the bin. The problem with this behavior is that the 
missing IV dose is still somewhere in the nursing unit, and it will remain unused and 
expire there. For these two reasons, the 5 drugs that are used to make these overstock IV 
solutions may be wasted at a higher rate than other drugs. 
 The other 5 drugs in the top 10 drugs wasted by number of bags include 
meropenem, phenylephrine, folic acid, thiamine, and multivitamin infuvite. There will be 
two sections later dedicated to meropenem and phenylephrine. As for the other three, 
they are frequently used in combination to make what is known as a "banana bag," named 
for the yellow color and the high vitamin concentration of the solution. These bags are 
infused continuously, so they are made as part of the IV batch that prints at scheduled 
times during the day. The solution has a short expiration time of 24 hours, so if a bag gets 
returned to the pharmacy after remaining unused in the nursing unit, there is almost never 
a chance for the bag to be recycled and given to another patient. During this study, 12 
"banana bags" were wasted, leading to its spot in the top 10 list. This finding is not 
surprising. Technicians often joke about the futility of making these multivitamin 
infusions because sometimes it feels like every "banana bag" they make gets returned and 
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wasted at the pharmacy a day later. The study result supports their observation because 
these solutions are indeed wasted at a higher rate than most other IV infusions. A possible 
strategy to mitigate the waste is to change these orders from scheduled to PRN, so that 
these bags are only made as needed.  
 The top 10 drug classes wasted include 5 different classes of antibiotics, 
electrolytes, vitamins, NSAIDs, alpha-adrenergic agonist, and anticonvulsant. The only 
NSAID in the results was ibuprofen, the only alpha-adrenergic agonist was phenylephrine, 
and the anticonvulsants were levetiracetam and valproic acid. Antibiotics are some of the 
most frequently used medication at hospitals, so it is not surprising that they are also 
some of the most frequently wasted solutions. These bags may remain unused due to 
order changes, patient discharge, or a variety of other factors. Electrolytes, vitamins, 
NSAIDs, and alpha-adrenergic agonist all showed up in the top 10 drugs wasted by 
number of bags list as well, and possible reasons for their wastage either have already 
been discussed or will be discussed (in the case of phenylephrine). Anticonvulsant was a 
surprising drug class in the top 10 list, but a quick look at the data shows that only 7 bags 
were wasted in this drug class, and since both levetiracetam and valproic acid have short 
expiration time of 24 hours, it is understandable that 7 bags could have been wasted in a 
month. 
 
2. Quantify the financial loss in terms of drug cost  
 The top ten drugs wasted by drug cost included 2 types of medications. The top 4 
drugs, namely vasopressin, daptomycin, ceftaroline fosamil, and nitroprusside, were in 
this list because the unit price for each drug was over $100. Vasopressin, for example, 
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costs $122.48 per 2 ml vial. Nitroprusside is even more expensive at $280.92 per 2 ml 
vial. Therefore, wasting just one IV bag made from one of these high-cost drugs can have 
the same financial impact as wasting dozens of bags made from a cheaper drug. The other 
6 drugs in this list (meropenem, norepinephrine, aztreonam, anidulafungin, sodium 
bicarbonate, and phenylephrine) are relatively cheaper, with unit prices under $50, but 
the sheer volume of bags wasted resulted in costly drug loss. It is important to note that 
wastage from these ten drugs constituted 71% of the total financial loss due to drug cost, 
so by focusing on strategies to reduce waste in these 10 drugs, the pharmacy can bring 
the cost down significantly. 
 The top ten drug classes wasted by drug cost reflect mostly similar results to the 
top ten drugs. 7 of the ten drug classes are represented in the top 10 drugs wasted by drug 
cost, and they are hormone analog antidiuretic (vasopressin), cyclic lipopeptide antibiotic 
(daptomycin), vasodilator antihypertensive (nitroprusside), antifungal (anidulafungin), 
carbapenem antibiotic (meropenem), alpha-/beta-agonist (norepinephrine), and 
monobactam antibiotic (aztreonam). The other three drug classes, cephalosporin 
antibiotics, electrolytes, and vitamins, were also in the top ten drug classes wasted by 
number of bags, so their presence in the top ten by drug cost list may be explained by the 
high volume of waste for each drug class.  
 
3. Common drugs and drug classes in top 10 wasted both by number of bags and by 
drug cost 
 There are two drugs that are in the top 10 drugs wasted both by number of bags 
and by drug cost: meropenem and phenylephrine. All 31 bags of meropenem that were 
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wasted came from Omnicell restocks, meaning that these bags were made in the 
pharmacy and put in the Omnicell machines by rounding technicians, but were never 
used by nurses prior to their expiration date. These pop-together meropenem preparations 
are given an expiration time of 15 days. They are kept in almost every nursing unit, in 
either the 500 mg or 1 g strength or both. Depending on the type of patients at each unit, 
demand for meropenem fluctuates greatly, so some units might need daily restocks of 
meropenem IV bags, while other units have a surplus of them. While the unit price of 
meropenem isn't high, 31 bags ended up costing the pharmacy nearly $200 in a month.  
 Meropenem wastage is not a problem unique to the BMH-NM (Oxford) pharmacy. 
Several papers have examined ways to reduce the cost of meropenem acquisition while 
maintaining clinical outcomes. In a paper published in the American Journal of Health-
System Pharmacy, Kotapati (2004) found that a dosing regimen of meropenem at 500 mg 
every 6 hours yielded similar clinical outcome to a dosing regimen of 1 g every 8 hours 
and reduced the daily drug acquisition cost for meropenem at  a large teaching hospital. 
Another study by Patel (2007) published in Pharmacotherapy confirmed that the 
alternative dosing regimen for meropenem reduced total daily dose and almost halved the 
drug cost in a 417-bed privately owned community hospital. So perhaps switching to this 
alternative dosing regimen and stocking only 500 mg meropenem in Omnicell machines 
can reduce cost. Still, there needs to be more research on whether this change can reduce 
wastage. 
 Phenylephrine infusions are usually PRN or as needed orders, but because of the 
frequency of use, some technicians like to make a couple extra bags to keep in the fridge 
so they don't have to go back into the IV room every other hour to make this IV solution. 
30 
 
Phenylephrine IV solutions are only good for 24 hours, so sometimes they expire in the 
fridge before being used. Other times, multiple bags are sent up to the nurse at once 
because the IV solution is flowing into the patient at a rapid rate continuously, and the 
nurse wants to makes sure there is no lag time between the first bag running dry and 
hanging of the second bag. Unfortunately not every bag is hung, and the extra bags either 
expire in the unit or are brought back to the pharmacy to be wasted. In the 30-day data 
collection period, 12 bags of phenylephrine were wasted, resulting in a loss of $121.2. 
While these numbers may seem low, this is still a drug that should be prioritized for 
reducing wastage because it was in the top 10 list for both wastage criteria.  
 Finally, there were 4 drug classes that were in the top 10 drug classes wasted both 
by number of bags and by drug cost, and Figure 15 showed how number of bags and cost 
related for each drug under these four drug classes. It becomes clear that for some drugs 
like ceftaroline fosamil, the cost is the driving factor behind its high wastage, whereas 
potassium chloride had 10 times more bags wasted than ceftaroline fosamil but only a 
quarter of the drug cost loss. The figure attempts to show that in order for the pharmacy 
to cut down IV solution wastage, they must consider volume and cost together to reduce 
financial loss. 
 
Practical Relevance 
 The data collection process brought forth a few unexpected insights into the 
practical relevance of this study. First, the daily data collection process was simple and 
quick, with time ranging from 10 minutes to 20 minutes per day to complete all the tasks, 
including entering data, crediting the bags, removing and shredding labels, and cutting 
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the bags up in the sink, all (except for data entry) of which are tasks that pharmacy 
technicians already do as a part of normal work routine. Therefore, a daily log of wasted 
IV solutions can be easily incorporated into the nightshift technician's work flow.  
 Second, the data collection process eased the workload of the rounding 
technicians by cutting out the time they would normally spend on crediting the wasted IV 
bag, and it eased the workload of the IV technicians by cutting out the time they would 
normally spend on cutting up the bags in the sink. In fact, at the conclusion of the data 
collection, several technicians said that they've been "spoiled" and would miss me 
coming to the pharmacy every night for data collection. 
 Third, the data collection process increased awareness of IV solution wastage, and 
even medication wastage in general, for both technicians and pharmacists. By the second 
week of data collection, the staff began asking me, "how are we doing today (in terms of 
number of bags wasted)?" By the third week, a few techs and pharmacists had picked up 
on the fact that meropenem was being wasted at a high rate, and one pharmacist remarked 
that she was wary of restocking Omnicell machines with meropenem because, "we would 
end up expiring them anyway." By the fourth week, which is the week that staff conducts 
medication expiration throughout the pharmacy and the Omnicell machines, the lead tech 
had asked me if I plan on collecting data on all medication wasted, i.e. pill, insulins, etc. 
because of the high volume of drugs being wasted that month. In a matter of 30 days, the 
pharmacy staff became more invested in IV solution wastage and more vocal about their 
concerns. If this project were continued for a longer period of time, the cultural change 
might be even more evident. 
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Study Limitations 
 There are a number of limitations with this study. First, the study was conducted 
in a rural hospital in Mississippi that serves a patient population with a distinct regional 
disease prevalence high in obesity, Type II diabetes, hypertension, and other 
cardiovascular diseases. The data, therefore, has low external validity. The findings of 
this study cannot be used to predict or to be compared to IV solution wastage patterns at 
larger hospitals in urban areas, or in specialty hospitals that cater to oncology patients or 
pediatrics.  
 Second, the study was conducted in a brief 30-day period in March. March is 
usually not the busiest month for hospitals, especially for BMH-NM (Oxford). At this 
hospital, peak inpatient census happens when the influenza season and the cold winter 
months collide, from October to February. Therefore, the wastage observed in this study 
might be an underestimate of the IV solution wastage in the winter months. On the other 
hand, March is usually busier than the summer months between June and August, so this 
study's findings might be an overestimate for those months. Clearly, the optimal study 
duration should be a yearlong study to accurately reflect the average amount of IV 
solution wastage per month, but due to constraints on time and resources, this study was 
only able to collect data from one month. 
 Third, the study only quantified one aspect of the financial loss, which is drug 
cost. This study did not take into account the cost of fluid bags in which the drugs were 
injected, nor the supply cost of making IV solutions (i.e. syringes, needles, sterile garbs, 
etc.), nor the labor cost of the pharmacy technicians and pharmacists. Therefore, the 
$4000 loss is only a portion of the total financial loss due to IV solution wastage. The 
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findings might be more striking if all aspects of financial loss were taken into account, 
but due to difficulties in obtaining fluid costs, supply costs, and employee pay rates, as 
well as constructing a model for calculating the labor cost per bag, this study only 
quantified the drug cost of IV solution wastage. Even the drug cost alone was calculated 
conservatively. For example, the drug cost from multidose vials was calculated with the 
assumption that each vial was used to make as many IV bags as possible before it was 
thrown away. In reality, multidose vials are frequently discarded with some drug still left 
in them, so the actual drug cost from multidose vials would be higher than what this 
study reflects. 
 Finally, this study did not investigate the cause of IV wastage. To identify the 
cause of waste for each bag, one would need access to each patient's electronic medical 
record, which is difficult to obtain as a researcher. One would also need a thorough 
understanding of the nursing workflow and physician workflow to fully investigate why 
some IV solutions remain unused. Therefore, while the result confirmed that IV wastage 
is costing the pharmacy a lot of money, this study cannot provide any definite answers on 
strategies to reduce IV wastage. 
 
Further Research 
 Some ideas for further research include expanding the study period from one 
month to a year to investigate the long-term impact of IV solution wastage, identifying 
and comparing IV solution wastage in two rural hospitals in Mississippi, and 
investigating the cause of IV solution wastage at a hospital pharmacy. 
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CONCLUSION 
 IV solution wastage is costing the BMH-NM (Oxford) pharmacy over $4000 per 
month, and identifying this problem is the first step in attempting to mitigate the wastage. 
Pharmacy directors can use wastage data to pinpoint areas for improvement and enact 
changes that can most effectively reduce IV solution wastage. 
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